Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Treg cells promote decidual vascular remodeling and modulate uterine NK cells in pregnant mice
Shanna L. Hosking, Lachlan M. Moldenhauer, Ha M. Tran, Hon Y. Chan, Holly M. Groome, Evangeline A.K. Lovell, Ella S. Green, Stephanie E. O’Hara, Claire T. Roberts, Kerrie L. Foyle, Sandra T. Davidge, Sarah A. Robertson, Alison S. Care
Shanna L. Hosking, Lachlan M. Moldenhauer, Ha M. Tran, Hon Y. Chan, Holly M. Groome, Evangeline A.K. Lovell, Ella S. Green, Stephanie E. O’Hara, Claire T. Roberts, Kerrie L. Foyle, Sandra T. Davidge, Sarah A. Robertson, Alison S. Care
View: Text | PDF
Research Article Immunology Reproductive biology

Treg cells promote decidual vascular remodeling and modulate uterine NK cells in pregnant mice

  • Text
  • PDF
Abstract

Regulatory T (Treg) cells are essential for maternal immune tolerance of the fetus and placenta. In preeclampsia, aberrant Treg cell tolerance is implicated, but how Treg cells affect the uterine vascular dysfunction thought to precede placental impairment and maternal vasculopathy is unclear. We used Foxp3-diphtheria toxin receptor mice to test the hypothesis that Treg cells are essential regulators of decidual spiral artery adaptation to pregnancy. Transient Treg cell depletion during early placental morphogenesis caused impaired remodeling of decidual spiral arteries, altered uterine artery function, and fewer Dolichos biflorus agglutinin+ uterine natural killer (uNK) cells, resulting in late-gestation fetal loss and fetal growth restriction. Replacing the Treg cells by transfer from wild-type donors mitigated the impact on uNK cells, vascular remodeling, and fetal loss. RNA sequencing of decidua revealed genes associated with NK cell function and placental extravillous trophoblasts were dysregulated after Treg cell depletion and normalized by Treg cell replacement. These data implicate Treg cells as essential upstream drivers of uterine vascular adaptation to pregnancy, through a mechanism likely involving phenotypic regulation of uNK cells and trophoblast invasion. The findings provide insight into mechanisms linking impaired adaptive immune tolerance and altered spiral artery remodeling, 2 hallmark features of preeclampsia.

Authors

Shanna L. Hosking, Lachlan M. Moldenhauer, Ha M. Tran, Hon Y. Chan, Holly M. Groome, Evangeline A.K. Lovell, Ella S. Green, Stephanie E. O’Hara, Claire T. Roberts, Kerrie L. Foyle, Sandra T. Davidge, Sarah A. Robertson, Alison S. Care

×

Figure 1

Effect of DT administration to Foxp3DTR mice in the peri-implantation period on uDLN Treg cell proportion and phenotype in midgestation.

Options: View larger image (or click on image) Download as PowerPoint
Effect of DT administration to Foxp3DTR mice in the peri-implantation pe...
Foxp3DTR mice were administered PBS (veh) or DT i.p. on GD3.5 and GD5.5. uDLNs were recovered on GD6.5 or GD10.5, and the proportion and phenotype of CD4+FOXP3+ Treg cells were evaluated using flow cytometry. (A) Representative contour plots show the proportion of CD4+FOXP3+ Treg cells in the uDLNs on GD6.5 from vehicle-treated (left) and DT-treated (right) Foxp3DTR mice. (B) The proportions of CD4+FOXP3+ Treg cells in uDLNs at GD6.5 and GD10.5. Detailed analysis of Treg cells at GD10.5 shows the proportion of Treg cells expressing NRP1 indicating thymic origin (C), proliferation marker Ki67 (D), and marker of suppressive competence CTLA4 (E). The proportion of IFN-γ+CD4+FOXP3– (Th1 cells; F) and IL-17a+CD4+FOXP3– (Th17 cells; G) were measured. N = 3–14 mice per group. Data are mean ± SEM. Data points are values from individual dams. Analysis was by 2-tailed t test or Mann-Whitney U test depending on normality of data distribution for data in C–G. Data in B were analyzed using a 1-way ANOVA comparing samples within the same gestational day. *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts